Last reviewed · How we verify
NCT06670092
Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder
NA trial testing Vojta Therapy in Attention Deficit Disorder With Hyperactivity in 20 participants. Completed in 3 March 2025.
20 January 2025
Quick facts
| Lead sponsor | Universidad Rey Juan Carlos |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 30 November 2024 |
| Primary completion | 20 January 2025 |
| Estimated completion | 3 March 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Vojta Therapy
- No intervetion
Conditions studied
- Attention Deficit Disorder With Hyperactivity — all drugs for Attention Deficit Disorder With Hyperactivity →
Sponsor
Universidad Rey Juan Carlos — full company profile →
Who can join
Adults 6 to 12, any sex, with Attention Deficit Disorder With Hyperactivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
ADHD is generally associated with significant comorbidities including motor disorders in up to 96% of cases. Within these, disturbances of balance and motor coordination that interfere with school learning and daily activities are present in 47% of school children with ADHD. Therefore, the aim of this research is to determine whether Vojta therapy is beneficial for the improvement of balance, postural control, hand-eye coordination and manipulative motor skills in children with ADHD, hyperactive and/or combined, aged 6-12 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06670092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vojta Therapy
Trials testing the same drug.
- NCT07248267 — Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome · NA · recruiting
- NCT05785962 — Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury. · NA · terminated
- NCT05410340 — EEG and NIRS in Preterm Infants · NA · enrolling by invitation
- NCT06092619 — Effects of Vojta Therapy on the Motor Function of Children With Neuromotor Disorders · NA · unknown
- NCT06159426 — Expert vs. Non-expert Abdominal Electromyographic Control in Vojta Therapy · NA · unknown
Other recruiting trials for Attention Deficit Disorder With Hyperactivity
Currently open trials in the same condition.
- NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT05621174 — The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD · NA · active not recruiting
- NCT06369714 — Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. · NA · recruiting
- NCT00001246 — Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers · active not recruiting
Other Universidad Rey Juan Carlos trials
Trials by the same sponsor.
- NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
- NCT07402902 — Caffeine Strategies and Fat Oxidation · NA · not yet recruiting
- NCT07251738 — Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease · not yet recruiting
- NCT07247760 — PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE · NA · enrolling by invitation
- NCT06968676 — Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06670092 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Rey Juan Carlos
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing